SCOPUS 정보 검색 플랫폼

Volumn 42, Issue 6, 2001, Pages 1329-1337

Rituximab toxicity in patients with peripheral blood malignant B-cell lymphocytosis

(6) Kanelli, Stamatina a Ansell, Stephen M b Habermann, Thomas M b Inwards, David J b Tuinstra, Nancy b Witzig, Thomas E b

a CHARLES UNIVERSITY (Czech Republic)

b MAYO CLINIC (United States)

Author keywords

Chronic lymphocytic leukemia; Non Hodgkin's lymphoma; Rituximab

Indexed keywords

AMPHOTERICIN B; CD20 ANTIGEN; CEFEPIME; CORTICOSTEROID; CREATININE; DIPHENHYDRAMINE; INTERLEUKIN 12; PARACETAMOL; PETHIDINE; RITUXIMAB;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; B LYMPHOCYTE; BRONCHOSPASM; CHILL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG SAFETY; DYSPNEA; FEMALE; FEVER; HOSPITALIZATION; HUMAN; HUMAN CELL; HYPOTENSION; LUNG DISEASE; LUNG TOXICITY; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; OUTPATIENT; PATIENT MONITORING; PRIORITY JOURNAL; RIGOR; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTOSIS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED;

EID: 0035697071 PISSN: 10428194 EISSN: None Source Type: Journal
DOI: 10.1080/10428190127502 Document Type: Article

Times cited : (44)

References (8)

1
- 1842368507
- "IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma"
- (1997) Blood , vol.90 , pp. 2188-2195
- Maloney, D.G.¹ Grillo-Lopez, A.J.² White, C.A.³ Bodkin, D.⁴ Schilder, R.J.⁵ Neidhart, J.A.⁶ Janakiraman, N.⁷ Foon, K.A.⁸ Liles, T.M.⁹ Dallaire, B.K.¹⁰ Wey, K.¹¹ Royston, I.¹² Davis, T.¹³ Levy, R.¹⁴

2
- 0345337254
- "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program"
- (1998) J. Clin. Oncol. , vol.16 , pp. 2825-2833
- McLaughlin, P.¹ Grillo-Lopez, A.J.² Link, B.K.³ Levy, R.⁴ Czuczman, M.S.⁵ Williams, M.E.⁶ Heyman, M.R.⁷ Bence-Bruckler, I.⁸ White, C.A.⁹ Cabanillas, F.¹⁰ Jain, V.¹¹ Ho, A.D.¹² Lister, J.¹³ Wey, K.¹⁴ Shen, D.¹⁵ Dallaire, B.K.¹⁶

3
- 0033016566
- "Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: Association with increased infusion-related side effects and rapid blood tumor clearance"
- (1999) J. Clin. Oncol. , vol.17 , pp. 791-795
- Byrd, J.C.¹ Waselenko, J.K.² Maneatis, T.J.³ Murphy, T.⁴ Ward, F.T.⁵ Monahan, B.P.⁶ Sipe, M.A.⁷ Donegan, S.⁸ White, C.A.⁹

4
- 0033214207
- "Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)"
- (1999) Blood , vol.94 , pp. 2217-2224
- Winkler, U.¹ Jensen, M.² Manzke, O.³ Schulz, H.⁴ Diehl, V.⁵ Engert, A.⁶

5
- 4243653893
- "Phase I study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin's lymphoma"
- (2000) Blood , vol.96
- Ansell, S.¹ Witzig, T.² Kurtin, P.³ Jelinek, D.⁴ Howell, K.⁵ Markovic, S.⁶ Habermann, T.⁷ Klee, G.⁸ Sloan, J.⁹ Erlichmann, C.¹⁰

6
- 0028217367
- "Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia"
- (1994) Am. J. Clin. Pathol. , vol.101 , pp. 312-317
- Witzig, T.E.¹ Li, C.Y.² Tefferi, A.³ Katzmann, J.A.⁴

7
- 0029763585
- "Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia"
- (1996) Am. J. Clin. Pathol. , vol.106 , pp. 457-461
- Tefferi, A.¹ Bartholmai, B.J.² Witzig, T.E.³ Li, C.Y.⁴ Hanson, C.A.⁵ Phyliky, R.L.⁶

8
- 0035091343
- "Antibody-targeted immunotherapy for treatment of malignancy"
- (2001) Annu. Rev. Med. , vol.52 , pp. 125-145
- White, C.A.¹ Weaver, R.L.² Grillo-Lopez, A.J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.